adesso (ADN1) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
31 Mar, 2026Executive summary
Achieved 14% organic sales growth in 2025, reaching EUR 1.47 billion, with strong profitable growth and a five-year average return on equity of 10.3%.
EBITDA rose 30% to EUR 123.6 million, at the upper end of guidance, with all targets fully met.
Germany remains the core market, contributing 84% of revenues, with strong sector diversification and no single sector or customer dominating.
Maintained a diversified portfolio with over 11,000 employees and a broad international presence, including SmartShore centers for scalable expertise and pricing.
Focused on expanding as a leading integrated IT company for sector-specific business processes in Europe, aiming to grow at least twice the market rate, with a sustainable operating margin and continuous dividend increases.
Financial highlights
Sales increased from EUR 1,286 million to EUR 1,466 million year-over-year, with EBITDA margin improving to 8.4%.
EBIT margin rose to 3.4% from 2.1% in 2024.
Earnings per share reached EUR 3.83, a significant improvement.
Dividend per share proposed at EUR 0.78, marking the thirteenth consecutive annual increase and totaling EUR 5 million.
Net working capital increased 28% to EUR 199 million, while operating cash flow declined 28% to EUR 85.6 million and free cash flow dropped to EUR 1.5 million.
Outlook and guidance
Revenue guidance for 2026 is EUR 1.6–1.7 billion (+9% to +16%), with EBITDA expected between EUR 130–150 million.
EBIT margin expected to improve only slightly in 2026; mid-term margin target remains 11%-13%.
Profitability expected to improve, aided by AI-driven development and two additional working days, though competition remains tense and hiring speed is reduced.
Continued focus on organic growth, with no large-scale M&A planned.
AI-driven modernization projects seen as a major growth opportunity, though productivity gains may pressure traditional business models.
Latest events from adesso
- Sales up 11% with margin pressure; H2 2025 expected to drive earnings recovery.ADN1
Q1 2025 TU3 Feb 2026 - Sales up 16% to €631.1m, but negative EPS and lower EBITDA guidance due to margin pressure.ADN1
H1 20241 Feb 2026 - Record sales and profitability in Q3 2024, with strong outlook and share buyback underway.ADN1
Q3 2024 TU14 Jan 2026 - Sales, EBITDA, and EPS surged, with robust sector growth and guidance at the upper end.ADN1
Q3 202515 Nov 2025 - 12% sales and 34% EBITDA growth in H1 2025, but free cash flow and equity ratio declined.ADN1
Q2 202518 Aug 2025 - 14% organic growth and margin gains set stage for further expansion in 2025.ADN1
H2 20245 Jun 2025